{"EPA_reg_num": "70271-31", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium hypochlorite\"]", "Product_name": "Nova", "Company": "KIK International LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1192}
{"EPA_reg_num": "67619-20", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Rex", "Company": "Clorox Professional Products Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 2.0, "Formulation_type": "[\"Ready-to-use\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1433}
{"EPA_reg_num": "71847-6", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium dichloroisocyanurate\"]", "Product_name": "Klorsept", "Company": "Medentech LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1493}
{"EPA_reg_num": "71847-7", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium dichloroisocyanurate\"]", "Product_name": "Klorkleen", "Company": "Medentech LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 4.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1494}
{"EPA_reg_num": "89492-2", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium chlorite\"]", "Product_name": "Dutrion Tablet", "Company": "Dutrion North America Ltd", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Rotavirus", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1665}